Detalle Publicación


GNAS mutations are not detected in parosteal and low-grade central osteosarcomas

Autores: Salinas-Souza, C.; De Andrea, Carlos Eduardo; Bihl, M.; Kovac, M.; Pillay, N.; Forshew, T.; Gutteridge, A.; Ye, H.; Amary, M. F.; Tirabosco, R.; Toledo, S. R. C.; Baumhoer, D.; Flanagan, A. M.
Título de la revista: MODERN PATHOLOGY
ISSN: 0893-3952
Volumen: 28
Número: 10
Páginas: 1336 - 1342
Fecha de publicación: 2015
Parosteal osteosarcoma, low-grade central osteosarcoma, and fibrous dysplasia share similar histological features that may pose a diagnostic challenge. The detection of GNAS mutations in primary bone tumors has been useful in clinical practice for diagnosing fibrous dysplasia. However, the recent report of GNAS mutations being detected in a significant proportion of parosteal osteosarcoma challenges the specificity of this mutation. As the number of cases reported in this study was small we set out to determine if these results could be reproduced. We studied 97 formalin-fixed paraffin-embedded low-grade osteosarcomas from 90 patients including 62 parosteal osteosarcomas, of which MDM2 amplification was detected in 79%, 11 periosteal osteosarcomas and 24 low-grade central osteosarcoma samples. The mutational status of GNAS was analyzed in codons p.R201, p.Q227, and other less common GNAS alterations by bidirectional Sanger sequencing and/or next generation sequencing using the Life Technologies Ion Torrent platform. GNAS mutations were not detected in any of the low-grade osteosarcomas from which informative DNA was extracted. Our findings therefore support prior observations that GNAS mutations are highly specific for fibrous dysplasia and occur rarely, if ever, in parosteal and other low-grade osteosarcomas.